Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Extended Platelet-Rich Fibrin (ePRF) Alone and in Combination With Bioactive Glass Nanoparticles in the Treatment of Grade II Furcation Defects

NCT07042204 is registered in ClinicalTrials.gov with Merna Nasser Mohamed Mostafa Ibrahim Elnahas as lead sponsor.

NCT NCT07042204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07042204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Extended Platelet-Rich Fibrin (ePRF) Alone and in Combination With Bioactive Glass Nanoparticles in the Treatment of Grade II Furcation Defects
Lead sponsor
Merna Nasser Mohamed Mostafa Ibrahim Elnahas
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2024
Completion date
August 3, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

furcation defects